BridgeMD
Measuring Oncological Value of Exercise and Statin (MOVES)
EU CTIS ID: 2024-515109-24-00
What this study is testing
1) Whether supervised group exercise with aerobic and resistance training during anticancer therapy improves the efficacy of anticancer therapy in advanced breast, renal, ovarian, and prostate cancer compared with self-administered exercise and whether the use of atorvastatin combined with supervised group exercise further improves the response to cancer treatment.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1) Patients with histologically and imaging confirmed metastatic prostate, breast, ovarian or renal cancer for which 1st line anticancer therapy is being initiated. 2) The patient consents to the study and signs a written informed consent. 3) Women (breast, ovarian and renal cancer) and men (prostate and renal cancer) of legal age (18 years =>) are recruited. 4) Women will use a reliable method of contraception during the trial.
You likely can't join if
- All patients: 1. High fracture risk 2. Unable to exercise and/or unable to receive anticancer therapy 3. Psychologically uncooperative 4. Severe liver or kidney failure 5. Special category of subjects under the Medical Research Act (1999/488) (e.g. minors and pregnant or breastfeeding women). In addition to excl. criteria for patients who were not on statin medication at the start of the study: Active use of cholesterol-lowering drugs, A history of serious side effects from cholesterol-lowering drugs and Continued use of drugs that interact with atorvastatin during the period of the study
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.